1932

Abstract

Abstract

The past decade has witnessed a significant growth in the identification of allosteric modulators of G protein–coupled receptors (GPCRs), i.e., ligands that interact with binding sites that are topographically distinct from the orthosteric site recognized by the receptor's endogenous agonist. Because of their ability to modulate receptor conformations in the presence of orthosteric ligand, allosteric modulators can “fine-tune” classical pharmacological responses. This is advantageous in terms of a potential for engendering greater GPCR subtype-selectivity, but represents a significant challenge for detecting and validating allosteric behaviors. Although allosteric sites need not have evolved to accommodate endogenous ligands, there are a number of examples of where such modulators have been shown to contribute to physiological or pathophysiological processes. Studies are also beginning to unravel the structural basis of allosteric modulation of GPCRs. It remains to be determined whether such modulation represents interactions within monomers versus across dimers.

Loading

Article metrics loading...

/content/journals/10.1146/annurev.pharmtox.47.120505.105159
2007-02-10
2024-04-25
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.pharmtox.47.120505.105159
Loading
/content/journals/10.1146/annurev.pharmtox.47.120505.105159
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error